HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristian Stengaard-Pedersen Selected Research

Methotrexate (Mexate)

3/2021Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial.
5/2020Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial.
2/2018Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate.
1/2018Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial.
5/2015A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
1/2015Methotrexate utilization in Rheumatoid arthritis. A register-based cohort-study of treatment re-starts after gabs of at least 90 days.
4/2014Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
9/2011[Methotrexate treatment of rheumatoid arthritis in Denmark].
10/2010Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
9/2010Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine. A prospective cohort study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristian Stengaard-Pedersen Research Topics

Disease

37Rheumatoid Arthritis
03/2021 - 12/2004
8Pain (Aches)
09/2018 - 06/2010
8Synovitis
10/2017 - 05/2006
7Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 01/2014
6Inflammation (Inflammations)
03/2021 - 01/2010
5Autoimmune Diseases (Autoimmune Disease)
01/2021 - 06/2015
3Arthritis (Polyarthritis)
01/2016 - 05/2013
3Osteoarthritis
10/2010 - 09/2009
2Rheumatic Diseases (Rheumatism)
01/2018 - 02/2017
2Tenosynovitis
10/2017 - 05/2015
2Experimental Arthritis
02/2017 - 01/2014
2Tennis Elbow (Elbow, Tennis)
06/2013 - 03/2013
1Arthralgia (Joint Pain)
01/2020
1Necrosis
01/2018
1Infections
03/2016
1Osteitis
05/2015
1Paresis (Hemiparesis)
06/2013
1Reperfusion Injury
01/2012
1Edema (Dropsy)
08/2011
1type 2 alpha 1 Collagenopathy
06/2010
1Knee Osteoarthritis
06/2010
1Hypertrichosis
05/2006
1Body Weight (Weight, Body)
05/2006

Drug/Important Bio-Agent (IBA)

14Methotrexate (Mexate)FDA LinkGeneric
03/2021 - 12/2004
8Anti-Citrullinated Protein AntibodiesIBA
01/2020 - 04/2009
6Antirheumatic Agents (DMARD)IBA
01/2018 - 09/2009
5Adalimumab (Humira)FDA Link
03/2021 - 04/2014
5AutoantibodiesIBA
03/2016 - 06/2010
4Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2015
3Complement System Proteins (Complement)IBA
11/2020 - 06/2015
3Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2020 - 05/2006
3LectinsIBA
01/2018 - 01/2012
3C-Reactive ProteinIBA
10/2017 - 06/2012
3Peptides (Polypeptides)IBA
02/2017 - 06/2010
3Rheumatoid FactorIBA
03/2016 - 08/2011
3Betamethasone (Celestone)FDA Link
06/2012 - 05/2006
2complement C3d,gIBA
11/2020 - 01/2018
2ametantrone (HAQ)IBA
09/2018 - 10/2017
2Biological ProductsIBA
02/2017 - 07/2015
2CytokinesIBA
06/2015 - 10/2010
2interleukin-21 (interleukin 21)IBA
06/2015 - 10/2010
2Triamcinolone (Aristocort)FDA Link
05/2015 - 04/2014
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2014 - 01/2014
2GlucocorticoidsIBA
06/2013 - 03/2013
2Immunoglobulin M (IgM)IBA
06/2012 - 08/2011
2SteroidsIBA
02/2012 - 09/2009
2cyclic citrullinated peptideIBA
08/2011 - 04/2009
2Opioid Analgesics (Opioids)IBA
10/2010 - 07/2010
2Buprenorphine (Subutex)FDA LinkGeneric
10/2010 - 07/2010
2Acetaminophen (Paracetamol)FDA LinkGeneric
07/2010 - 06/2010
1LDL CholesterolIBA
03/2021
1LipidsIBA
03/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1LigandsIBA
01/2020
1Vitamin DFDA LinkGeneric
09/2018
11,25-dihydroxyvitamin DIBA
09/2018
1VitaminsIBA
09/2018
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
02/2018
1Circulating MicroRNAIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1MicroRNAs (MicroRNA)IBA
01/2018
1ElementsIBA
02/2017
1Toll-Like Receptor 7IBA
02/2017
1Glycoproteins (Glycoprotein)IBA
02/2017
1Interleukin-6 (Interleukin 6)IBA
02/2017
1Immunoglobulins (Immunoglobulin)IBA
01/2017
1DisintegrinsIBA
10/2016
1interleukin-20 receptorIBA
03/2016
1InterleukinsIBA
06/2015
1Serine Proteases (Serine Protease)IBA
06/2015
1Toll-Like Receptor 3IBA
10/2014
1Indicators and Reagents (Reagents)IBA
09/2014
1Parathyroid Hormone (Parathormone)IBA
01/2014
1Zoledronic Acid (Zometa)FDA Link
01/2014
1FicolinsIBA
12/2013
1Botulinum Toxins (Botulinum Toxin)IBA
06/2013
1MannansIBA
05/2013
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2013
1ZymosanIBA
05/2013
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
02/2012
1Pharmaceutical PreparationsIBA
09/2011
1Aligeron (AS 2)IBA
08/2011
1Cartilage Oligomeric Matrix ProteinIBA
08/2011
1Interleukin-23 (Interleukin 23)IBA
10/2010
1Interleukin-17 (Interleukin 17)IBA
10/2010
1Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA
07/2010
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2010
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2010
1AntibodiesIBA
06/2010
1Hyaluronic Acid (Hyaluronan)IBA
06/2010
1CollagenIBA
06/2010
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
01/2010
1AdiponectinIBA
09/2009
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
04/2009
1CXC ChemokinesIBA
09/2006
1Chemokine CXCL12IBA
09/2006

Therapy/Procedure

7Therapeutics
01/2017 - 05/2006
3Intra-Articular Injections
06/2012 - 06/2010
2Injections
05/2015 - 06/2012
2Transdermal Patch
10/2010 - 07/2010